Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli

New antibiotics are required to treat bacterial infections and counteract the emergence of antibiotic resistance. Pathogen-specific antibiotics have several advantages over broad-spectrum drugs, which include minimal perturbation to the commensal microbiota. We present a strategy for targeting antib...

Full description

Bibliographic Details
Main Authors: Chairatana, Phoom, Zheng, Tengfei, Nolan, Elizabeth Marie
Other Authors: Massachusetts Institute of Technology. Department of Chemistry
Format: Article
Language:en_US
Published: Royal Society of Chemistry 2016
Online Access:http://hdl.handle.net/1721.1/104034
https://orcid.org/0000-0002-6153-8803
https://orcid.org/0000-0002-5356-3638
_version_ 1811078690909454336
author Chairatana, Phoom
Zheng, Tengfei
Nolan, Elizabeth Marie
author2 Massachusetts Institute of Technology. Department of Chemistry
author_facet Massachusetts Institute of Technology. Department of Chemistry
Chairatana, Phoom
Zheng, Tengfei
Nolan, Elizabeth Marie
author_sort Chairatana, Phoom
collection MIT
description New antibiotics are required to treat bacterial infections and counteract the emergence of antibiotic resistance. Pathogen-specific antibiotics have several advantages over broad-spectrum drugs, which include minimal perturbation to the commensal microbiota. We present a strategy for targeting antibiotics to bacterial pathogens that utilises the salmochelin-mediated iron uptake machinery of Gram-negative Escherichia coli. Salmochelins are C-glucosylated derivatives of the siderophore enterobactin. The biosynthesis and utilisation of salmochelins are important for virulence because these siderophores allow pathogens to acquire iron and evade the enterobactin-scavenging host-defense protein lipocalin-2. Inspired by the salmochelins, we report the design and chemoenzymatic preparation of glucosylated enterobactin–β-lactam conjugates that harbour the antibiotics ampicillin (Amp) and amoxicillin (Amx), hereafter GlcEnt–Amp/Amx. The GlcEnt scaffolds are based on mono- and diglucosylated Ent where one catechol moiety is functionalized at the C5 position for antibiotic attachment. We demonstrate that GlcEnt–Amp/Amx provide up to 1000-fold enhanced antimicrobial activity against uropathogenic E. coli relative to the parent β-lactams. Moreover, GlcEnt–Amp/Amx based on a diglucosylated Ent (DGE) platform selectively kill uropathogenic E. coli that express the salmochelin receptor IroN in the presence of non-pathogenic E. coli and other bacterial strains that include the commensal microbe Lactobacillus rhamnosus GG. Moreover, GlcEnt–Amp/Amx evade the host-defense protein lipocalin-2, and exhibit low toxicity to mammalian cells. Our work establishes that siderophore–antibiotic conjugates provide a strategy for targeting virulence, narrowing the activity spectrum of antibiotics in clinical use, and achieving selective delivery of antibacterial cargos to pathogenic bacteria on the basis of siderophore receptor expression.
first_indexed 2024-09-23T11:03:36Z
format Article
id mit-1721.1/104034
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T11:03:36Z
publishDate 2016
publisher Royal Society of Chemistry
record_format dspace
spelling mit-1721.1/1040342022-10-01T00:54:55Z Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli Chairatana, Phoom Zheng, Tengfei Nolan, Elizabeth Marie Massachusetts Institute of Technology. Department of Chemistry Chairatana, Phoom Zheng, Tengfei Nolan, Elizabeth Marie New antibiotics are required to treat bacterial infections and counteract the emergence of antibiotic resistance. Pathogen-specific antibiotics have several advantages over broad-spectrum drugs, which include minimal perturbation to the commensal microbiota. We present a strategy for targeting antibiotics to bacterial pathogens that utilises the salmochelin-mediated iron uptake machinery of Gram-negative Escherichia coli. Salmochelins are C-glucosylated derivatives of the siderophore enterobactin. The biosynthesis and utilisation of salmochelins are important for virulence because these siderophores allow pathogens to acquire iron and evade the enterobactin-scavenging host-defense protein lipocalin-2. Inspired by the salmochelins, we report the design and chemoenzymatic preparation of glucosylated enterobactin–β-lactam conjugates that harbour the antibiotics ampicillin (Amp) and amoxicillin (Amx), hereafter GlcEnt–Amp/Amx. The GlcEnt scaffolds are based on mono- and diglucosylated Ent where one catechol moiety is functionalized at the C5 position for antibiotic attachment. We demonstrate that GlcEnt–Amp/Amx provide up to 1000-fold enhanced antimicrobial activity against uropathogenic E. coli relative to the parent β-lactams. Moreover, GlcEnt–Amp/Amx based on a diglucosylated Ent (DGE) platform selectively kill uropathogenic E. coli that express the salmochelin receptor IroN in the presence of non-pathogenic E. coli and other bacterial strains that include the commensal microbe Lactobacillus rhamnosus GG. Moreover, GlcEnt–Amp/Amx evade the host-defense protein lipocalin-2, and exhibit low toxicity to mammalian cells. Our work establishes that siderophore–antibiotic conjugates provide a strategy for targeting virulence, narrowing the activity spectrum of antibiotics in clinical use, and achieving selective delivery of antibacterial cargos to pathogenic bacteria on the basis of siderophore receptor expression. Massachusetts Institute of Technology. Department of Chemistry National Institutes of Health (U.S.) (Pacific Southwest Research Center of Excellence for Biodefense and Emerging Infectious Disease) Kinship Foundation. Searle Scholars Program Royal Thai Government (RTG) (Scholarship program) 2016-08-26T16:20:58Z 2016-08-26T16:20:58Z 2015-05 2015-03 Article http://purl.org/eprint/type/JournalArticle 2041-6520 2041-6539 http://hdl.handle.net/1721.1/104034 Chairatana, Phoom, Tengfei, Zheng, and Elizabeth M. Nolan. "Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli." Chemical Science 6 (2015), pp.4458-4471. © Royal Society of Chemistry 2016. https://orcid.org/0000-0002-6153-8803 https://orcid.org/0000-0002-5356-3638 en_US http://dx.doi.org/10.1039/c5sc00962f Chemical Science Creative Commons Attribution-NonCommercial 3.0 Unported licence http://creativecommons.org/licenses/by-nc/3.0/ application/pdf Royal Society of Chemistry Royal Society of Chemistry
spellingShingle Chairatana, Phoom
Zheng, Tengfei
Nolan, Elizabeth Marie
Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli
title Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli
title_full Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli
title_fullStr Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli
title_full_unstemmed Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli
title_short Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli
title_sort targeting virulence salmochelin modification tunes the antibacterial activity spectrum of β lactams for pathogen selective killing of escherichia coli
url http://hdl.handle.net/1721.1/104034
https://orcid.org/0000-0002-6153-8803
https://orcid.org/0000-0002-5356-3638
work_keys_str_mv AT chairatanaphoom targetingvirulencesalmochelinmodificationtunestheantibacterialactivityspectrumofblactamsforpathogenselectivekillingofescherichiacoli
AT zhengtengfei targetingvirulencesalmochelinmodificationtunestheantibacterialactivityspectrumofblactamsforpathogenselectivekillingofescherichiacoli
AT nolanelizabethmarie targetingvirulencesalmochelinmodificationtunestheantibacterialactivityspectrumofblactamsforpathogenselectivekillingofescherichiacoli